potassium chloride extended release

Generic: potassium chloride

Labeler: rising pharma holdings, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name potassium chloride extended release
Generic Name potassium chloride
Labeler rising pharma holdings, inc.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

potassium chloride 750 mg/1

Manufacturer
Rising Pharma Holdings, Inc.

Identifiers & Regulatory

Product NDC 16571-843
Product ID 16571-843_1e184d68-6ad3-484c-9b26-dc835ed91cbb
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA217412
Listing Expiration 2027-12-31
Marketing Start 2025-02-13

Pharmacologic Class

Classes
increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] osmotic activity [moa] osmotic laxative [epc] potassium compounds [cs] potassium salt [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 16571843
Hyphenated Format 16571-843

Supplemental Identifiers

RxCUI
312529 628953
UNII
660YQ98I10

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name potassium chloride extended release (source: ndc)
Generic Name potassium chloride (source: ndc)
Application Number ANDA217412 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 750 mg/1
source: ndc
Packaging
  • 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-843-01)
  • 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-843-10)
  • 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-843-50)
source: ndc

Packages (3)

16571-843-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-843-01) 16571-843-10 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-843-10) 16571-843-50 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-843-50)

Ingredients (1)

potassium chloride (750 mg/1)

Linked Drug Pages (1)

POTASSIUM CHLORIDE EXTENDED RELEASE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "1e184d68-6ad3-484c-9b26-dc835ed91cbb", "openfda": {"unii": ["660YQ98I10"], "rxcui": ["312529", "628953"], "spl_set_id": ["947c11ca-ca0c-42df-8cc5-3db06458ca5b"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-843-01)", "package_ndc": "16571-843-01", "marketing_start_date": "20250213"}, {"sample": false, "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-843-10)", "package_ndc": "16571-843-10", "marketing_start_date": "20250918"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-843-50)", "package_ndc": "16571-843-50", "marketing_start_date": "20250213"}], "brand_name": "POTASSIUM CHLORIDE EXTENDED RELEASE", "product_id": "16571-843_1e184d68-6ad3-484c-9b26-dc835ed91cbb", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Potassium Compounds [CS]", "Potassium Salt [EPC]"], "product_ndc": "16571-843", "generic_name": "potassium chloride", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "POTASSIUM CHLORIDE EXTENDED RELEASE", "active_ingredients": [{"name": "POTASSIUM CHLORIDE", "strength": "750 mg/1"}], "application_number": "ANDA217412", "marketing_category": "ANDA", "marketing_start_date": "20250213", "listing_expiration_date": "20271231"}